CAPITOL HILL CONSULTING GROUP for ELI LILLY AND COMPANY
A later version of this report replaces this one, so LegiList's totals use the current version instead. This page shows this version exactly as filed.
Versions of this report
Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.
| Filing | Filed | Amount | Counted |
|---|---|---|---|
| 1st Quarter - Report (this page) | Apr 28, 2008 | $20,000 | Replaced |
| 1st Quarter - Amendment | Apr 28, 2008 | $20,000 | Yes |
What was lobbied
5 issue areas, each in the filer's own words, with who lobbied on it and where.
Taxation/Internal Revenue Code TAX
General tax issues pertaining to Eli Lilly and Company
| Lobbyist | Covered position, as disclosed |
|---|---|
| BILL K BREWSTER | — |
| STEVEN E IRIZARRY New | — |
Health Issues HCR
General healthcare issues pertaining to Eli Lilly and Company, including but not limited to, drug imporation
| Lobbyist | Covered position, as disclosed |
|---|---|
| BILL K BREWSTER | — |
| STEVEN E IRIZARRY New | — |
Government Issues GOV
general patent issues
| Lobbyist | Covered position, as disclosed |
|---|---|
| BILL K BREWSTER | — |
| STEVEN E IRIZARRY New | — |
Pharmacy PHA
General Pharmaceutical issues pertaining to Eli Lilly Company, including but not limited to: The Federal Food, Drug and Cosmetic Act; the Hatch-Waxman Act; and drug inportation
| Lobbyist | Covered position, as disclosed |
|---|---|
| BILL K BREWSTER | — |
| STEVEN E IRIZARRY New | — |
Medicare/Medicaid MMM
General Medicare and Medicaid issues pertaining to Eli Lilly Company, including but not limited to, coverage and reimbursement
| Lobbyist | Covered position, as disclosed |
|---|---|
| BILL K BREWSTER | — |
| STEVEN E IRIZARRY New | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.